Fresenius Medical Care AG (FMS)
22.17
+0.04
(+0.18%)
USD |
NYSE |
Oct 16, 16:00
22.29
+0.12
(+0.54%)
After-Hours: 20:00
Fresenius Medical Care Research and Development Expense (Annual) : 178.29M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 178.29M |
| December 31, 2024 | 198.48M |
| December 31, 2023 | 250.79M |
| December 31, 2022 | 240.28M |
| December 31, 2021 | 260.96M |
| December 31, 2020 | 220.90M |
| December 31, 2019 | 188.07M |
| December 31, 2018 | 157.63M |
| December 31, 2017 | 147.43M |
| December 31, 2016 | 162.07M |
| December 31, 2015 | 139.64M |
| December 31, 2014 | 120.26M |
| December 31, 2013 | 125.89M |
| December 31, 2012 | 112.45M |
| December 31, 2011 | 111.06M |
| Date | Value |
|---|---|
| December 31, 2010 | 96.56M |
| December 31, 2009 | 94.16M |
| December 31, 2008 | 80.24M |
| December 31, 2007 | 66.48M |
| December 31, 2006 | 51.68M |
| December 31, 2005 | 51.01M |
| December 31, 2004 | 51.29M |
| December 31, 2003 | 49.67M |
| December 31, 2002 | 47.43M |
| December 31, 2001 | 35.57M |
| December 31, 2000 | 31.93M |
| December 31, 1999 | 59.79M |
| December 31, 1998 | 31.15M |
| December 31, 1997 | 22.16M |
| December 31, 1996 | 14.03M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| DaVita, Inc. | -- |
| Rhön-Klinikum AG | -- |
| FamiCord AG | 0.948M |
| Quest Diagnostics, Inc. | -- |
| Acadia Healthcare Co., Inc. | -- |